APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bicalutamide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Bicalutamide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025187 pages

Choose your research edition.

Industry ResearchBicalutamide Tablets Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Bicalutamide Tablets Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Bicalutamide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bicalutamide Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Bicalutamide Tablets Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Bicalutamide Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Bicalutamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bicalutamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bicalutamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Bicalutamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bicalutamide Tablets include HISUN, Fosun Pharma, FORWARD, AstraZeneca and CordenPharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bicalutamide Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bicalutamide Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bicalutamide Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bicalutamide Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Bicalutamide Tablets Segment by Company

HISUN

Fosun Pharma

FORWARD

AstraZeneca

CordenPharma

Bicalutamide Tablets Segment by Type

14 Tablets Per Box

28 Tablets Per Box

Bicalutamide Tablets Segment by Application

Hospital

Clinic

Bicalutamide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bicalutamide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bicalutamide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bicalutamide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bicalutamide Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bicalutamide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Bicalutamide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Bicalutamide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Bicalutamide Tablets Industry Trends Table 2. Bicalutamide Tablets Industry Drivers Table 3. Bicalutamide Tablets Industry Opportunities and Challenges Table 4. Bicalutamide Tablets Industry Restraints Table 5. Global Bicalutamide Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Bicalutamide Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Bicalutamide Tablets Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Bicalutamide Tablets Sales Market Share by Manufacturers Table 9. Global Bicalutamide Tablets Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Bicalutamide Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Bicalutamide Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Bicalutamide Tablets Manufacturers, Product Type & Application Table 13. Global Bicalutamide Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Bicalutamide Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 14 Tablets Per Box Table 17. Major Manufacturers of 28 Tablets Per Box Table 18. Global Bicalutamide Tablets Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Bicalutamide Tablets Sales by Type (2021-2026) & (k units) Table 20. Global Bicalutamide Tablets Sales by Type (2027-2032) & (k units) Table 21. Global Bicalutamide Tablets Sales Market Share by Type (2021-2026) Table 22. Global Bicalutamide Tablets Sales Market Share by Type (2027-2032) Table 23. Global Bicalutamide Tablets Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Bicalutamide Tablets Revenue by Type (2021-2026) & (k units) Table 25. Global Bicalutamide Tablets Revenue by Type (2027-2032) & (k units) Table 26. Global Bicalutamide Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Bicalutamide Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Bicalutamide Tablets Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Bicalutamide Tablets Sales by Application (2021-2026) & (k units) Table 32. Global Bicalutamide Tablets Sales by Application (2027-2032) & (k units) Table 33. Global Bicalutamide Tablets Sales Market Share by Application (2021-2026) Table 34. Global Bicalutamide Tablets Sales Market Share by Application (2027-2032) Table 35. Global Bicalutamide Tablets Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Bicalutamide Tablets Revenue by Application (2021-2026) & (k units) Table 37. Global Bicalutamide Tablets Revenue by Application (2027-2032) & (k units) Table 38. Global Bicalutamide Tablets Revenue Market Share by Application (2021-2026) Table 39. Global Bicalutamide Tablets Revenue Market Share by Application (2027-2032) Table 40. Global Bicalutamide Tablets Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Bicalutamide Tablets Sales by Region (2021-2026) & (k units) Table 42. Global Bicalutamide Tablets Sales Market Share by Region (2021-2026) Table 43. Global Bicalutamide Tablets Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Bicalutamide Tablets Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Bicalutamide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Bicalutamide Tablets Sales by Country (2021-2026) & (k units) Table 47. North America Bicalutamide Tablets Sales by Country (2027-2032) & (k units) Table 48. Europe Bicalutamide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Bicalutamide Tablets Sales by Country (2021-2026) & (k units) Table 50. Europe Bicalutamide Tablets Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Bicalutamide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Bicalutamide Tablets Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Bicalutamide Tablets Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Bicalutamide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Bicalutamide Tablets Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Bicalutamide Tablets Sales by Country (2027-2032) & (k units) Table 57. Global Bicalutamide Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Bicalutamide Tablets Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Bicalutamide Tablets Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Bicalutamide Tablets Revenue Market Share by Region (2021-2026) Table 61. Global Bicalutamide Tablets Revenue Market Share by Region (2027-2032) Table 62. HISUN Company Information Table 63. HISUN Business Overview Table 64. HISUN Bicalutamide Tablets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. HISUN Bicalutamide Tablets Product Portfolio Table 66. HISUN Recent Development Table 67. Fosun Pharma Company Information Table 68. Fosun Pharma Business Overview Table 69. Fosun Pharma Bicalutamide Tablets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Fosun Pharma Bicalutamide Tablets Product Portfolio Table 71. Fosun Pharma Recent Development Table 72. FORWARD Company Information Table 73. FORWARD Business Overview Table 74. FORWARD Bicalutamide Tablets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. FORWARD Bicalutamide Tablets Product Portfolio Table 76. FORWARD Recent Development Table 77. AstraZeneca Company Information Table 78. AstraZeneca Business Overview Table 79. AstraZeneca Bicalutamide Tablets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. AstraZeneca Bicalutamide Tablets Product Portfolio Table 81. AstraZeneca Recent Development Table 82. CordenPharma Company Information Table 83. CordenPharma Business Overview Table 84. CordenPharma Bicalutamide Tablets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. CordenPharma Bicalutamide Tablets Product Portfolio Table 86. CordenPharma Recent Development Table 87. Key Raw Materials Table 88. Raw Materials Key Suppliers Table 89. Bicalutamide Tablets Distributors List Table 90. Bicalutamide Tablets Customers List Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Bicalutamide Tablets Product Image Figure 2. Global Bicalutamide Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bicalutamide Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Bicalutamide Tablets Sales (2021-2032) & (k units) Figure 5. Global Bicalutamide Tablets Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Bicalutamide Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 14 Tablets Per Box Image Figure 9. 28 Tablets Per Box Image Figure 10. Global Bicalutamide Tablets Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Bicalutamide Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Bicalutamide Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Bicalutamide Tablets Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Bicalutamide Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Bicalutamide Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Bicalutamide Tablets Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Bicalutamide Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Bicalutamide Tablets Sales Market Share by Application (2021-2032) Figure 21. Global Bicalutamide Tablets Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Bicalutamide Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Bicalutamide Tablets Revenue Market Share by Application (2021-2032) Figure 24. North America Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Bicalutamide Tablets Sales Market Share by Country (2021-2032) Figure 26. U.S. Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Bicalutamide Tablets Sales Market Share by Country (2021-2032) Figure 31. Germany Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Bicalutamide Tablets Sales Market Share by Country (2021-2032) Figure 38. China Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Bicalutamide Tablets Sales Market Share by Country (2021-2032) Figure 46. Brazil Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Bicalutamide Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Bicalutamide Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Bicalutamide Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Figure 57. North America Bicalutamide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Figure 59. Europe Bicalutamide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Bicalutamide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Bicalutamide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Bicalutamide Tablets Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Bicalutamide Tablets Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 14 Tablets Per Box
  • 28 Tablets Per Box
Applications
  • Hospital
  • Clinic
Companies covered
  • HISUN
  • Fosun Pharma
  • FORWARD
  • AstraZeneca
  • CordenPharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bicalutamide Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bicalutamide Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Bicalutamide Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Bicalutamide Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Bicalutamide Tablets Market Dynamics
  1. 2.1 Bicalutamide Tablets Industry Trends
  2. 2.2 Bicalutamide Tablets Industry Drivers
  3. 2.3 Bicalutamide Tablets Industry Opportunities and Challenges
  4. 2.4 Bicalutamide Tablets Industry Restraints
3 Bicalutamide Tablets Market by Manufacturers
  1. 3.1 Global Bicalutamide Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Bicalutamide Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Bicalutamide Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Bicalutamide Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bicalutamide Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Bicalutamide Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Bicalutamide Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bicalutamide Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bicalutamide Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bicalutamide Tablets Tier 1, Tier 2, and Tier 3
4 Bicalutamide Tablets Market by Type
  1. 4.1 Bicalutamide Tablets Type Introduction
  2. 4.1.1 14 Tablets Per Box
  3. 4.1.2 28 Tablets Per Box
  4. 4.2 Global Bicalutamide Tablets Sales by Type
  5. 4.2.1 Global Bicalutamide Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bicalutamide Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Bicalutamide Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Bicalutamide Tablets Revenue by Type
  9. 4.3.1 Global Bicalutamide Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bicalutamide Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Bicalutamide Tablets Revenue Market Share by Type (2021-2032)
5 Bicalutamide Tablets Market by Application
  1. 5.1 Bicalutamide Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Bicalutamide Tablets Sales by Application
  5. 5.2.1 Global Bicalutamide Tablets Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Bicalutamide Tablets Sales by Application (2021-2032)
  7. 5.2.3 Global Bicalutamide Tablets Sales Market Share by Application (2021-2032)
  8. 5.3 Global Bicalutamide Tablets Revenue by Application
  9. 5.3.1 Global Bicalutamide Tablets Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Bicalutamide Tablets Revenue by Application (2021-2032)
  11. 5.3.3 Global Bicalutamide Tablets Revenue Market Share by Application (2021-2032)
6 Global Bicalutamide Tablets Sales by Region
  1. 6.1 Global Bicalutamide Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bicalutamide Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Bicalutamide Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Bicalutamide Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bicalutamide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Bicalutamide Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Bicalutamide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Bicalutamide Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Bicalutamide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Bicalutamide Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Bicalutamide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Bicalutamide Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Bicalutamide Tablets Revenue by Region
  1. 7.1 Global Bicalutamide Tablets Revenue by Region
  2. 7.1.1 Global Bicalutamide Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Bicalutamide Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Bicalutamide Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Bicalutamide Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Bicalutamide Tablets Revenue (2021-2032)
  8. 7.2.2 North America Bicalutamide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Bicalutamide Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Bicalutamide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Bicalutamide Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Bicalutamide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Bicalutamide Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Bicalutamide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 HISUN
  2. 8.1.1 HISUN Company Information
  3. 8.1.2 HISUN Business Overview
  4. 8.1.3 HISUN Bicalutamide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 HISUN Bicalutamide Tablets Product Portfolio
  6. 8.1.5 HISUN Recent Developments
  7. 8.2 Fosun Pharma
  8. 8.2.1 Fosun Pharma Company Information
  9. 8.2.2 Fosun Pharma Business Overview
  10. 8.2.3 Fosun Pharma Bicalutamide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Fosun Pharma Bicalutamide Tablets Product Portfolio
  12. 8.2.5 Fosun Pharma Recent Developments
  13. 8.3 FORWARD
  14. 8.3.1 FORWARD Company Information
  15. 8.3.2 FORWARD Business Overview
  16. 8.3.3 FORWARD Bicalutamide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 FORWARD Bicalutamide Tablets Product Portfolio
  18. 8.3.5 FORWARD Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Bicalutamide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Bicalutamide Tablets Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 CordenPharma
  26. 8.5.1 CordenPharma Company Information
  27. 8.5.2 CordenPharma Business Overview
  28. 8.5.3 CordenPharma Bicalutamide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CordenPharma Bicalutamide Tablets Product Portfolio
  30. 8.5.5 CordenPharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bicalutamide Tablets Value Chain Analysis
  2. 9.1.1 Bicalutamide Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bicalutamide Tablets Production Mode & Process
  6. 9.2 Bicalutamide Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bicalutamide Tablets Distributors
  9. 9.2.3 Bicalutamide Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst